106
Views
7
CrossRef citations to date
0
Altmetric
Papers

Interactive role of human immunodeficiency virus type 1 (HIV-1) clade-specific Tat protein and cocaine in blood-brain barrier dysfunction: Implications for HIV-1–associated neurocognitive disorder

, , , , , , , & show all
Pages 294-305 | Received 24 May 2010, Accepted 27 May 2010, Published online: 12 Jul 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Mayur Doke, Venkatesh Jeganathan, Jay P. McLaughlin & Thangavel Samikkannu. (2021) HIV-1 Tat and cocaine impact mitochondrial epigenetics: effects on DNA methylation. Epigenetics 16:9, pages 980-999.
Read now
A. Borrajo, C. Spuch, M. A. Penedo, J. M. Olivares & R. C. Agís-Balboa. (2021) Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis. Annals of Medicine 53:1, pages 43-69.
Read now
MaryPeace McRae. (2016) HIV and viral protein effects on the blood brain barrier. Tissue Barriers 4:1.
Read now
Rahul Dev Jayant, Venkata SR Atluri, Marisela Agudelo, Vidya Sagar, Ajeet Kaushik & Madhavan Nair. (2015) Sustained-release nanoART formulation for the treatment of neuroAIDS. International Journal of Nanomedicine 10, pages 1077-1093.
Read now
Upal Roy, Hong Ding, Sudheesh Pilakka-Kanthikeel, Andrea D Raymond, Venkata Atluri, Adriana Yndart, Elena M Kaftanovskaya, Elena Batrakova, Marisela Agudelo & Madhavan Nair. (2015) Preparation and characterization of anti-HIV nanodrug targeted to microfold cell of gut-associated lymphoid tissue. International Journal of Nanomedicine 10, pages 5819-5835.
Read now
Randi Melissa Schuster & Raul Gonzalez. (2012) Substance abuse, hepatitis C, and aging in HIV: common cofactors that contribute to neurobehavioral disturbances. Neurobehavioral HIV Medicine 4, pages 15-34.
Read now
Florence Miller, Philippe V. Afonso, Antoine Gessain & Pierre-Emmanuel Ceccaldi. (2012) Blood-brain barrier and retroviral infections. Virulence 3:2, pages 222-229.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.